(Q50872362)

24 March 2018

title

Reduced status of plasma total antioxidant capacity in schizophrenia (English)

1 reference

24 March 2018

0 references

J K Yao

1

1 reference

24 March 2018

R Reddy

series ordinal

2

1 reference

24 March 2018

L G McElhinny

series ordinal

3

1 reference

24 March 2018

D P van Kammen

series ordinal

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

24 March 2018

published in

Schizophrenia Research

1 reference

24 March 2018

volume

32

1 reference

24 March 2018

issue

1

1 reference

24 March 2018

page(s)

1-8

1 reference

24 March 2018

Methods for reliable longitudinal observation of behavior

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Blood cotinine levels as indicators of smoking treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

The antioxidants of human extracellular fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Comparison of tests used to distinguish smokers from nonsmokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Determinants of antioxidant status in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

A comparison of antioxidant status and free radical peroxidation of plasma lipoproteins in healthy young persons from Naples and Bristol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Increased pentane and carbon disulfide in the breath of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Free radical pathology in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

Reduced level of plasma antioxidant uric acid in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900030-9

7 January 2021

10.1016/S0920-9964(98)00030-9

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018